Personalizando a medicina – estratégias para implementar a avaliação do rearranjo do ‘anaplastic lymphoma kinase’ no carcinoma do pulmão de não pequenas células em Portugal-Reference-Cited by-同舟云学术

Personalizando a medicina – estratégias para implementar a avaliação do rearranjo do ‘anaplastic lymphoma kinase’ no carcinoma do pulmão de não pequenas células em Portugal

Published:2012-09 Issue:5 Volume:18 Page:244-246
ISSN:0873-2159
Container-title:Revista Portuguesa de Pneumologia
language:pt
Short-container-title:Revista Portuguesa de Pneumologia

Author:

Araújo A.,Coelho A.,de Mello R.A.,Azevedo I.,Soares M.,Queiroga H.,Teixeira E.,Parente B.,Barata F.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference17 articles.

1. GLOBOCAN 2008 (IARC). http://globocan.iarc.fr/factsheets/populations/factsheet.asp?uno=620 (11 July 2011, date last accessed)

2. New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions;Bunn;Clin Cancer Res,1998

3. Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens The TAX 320 Non-Small Cell Lung Cancer Study Group;Fossella;J Clin Oncol,2000

4. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy;Shepherd;J Clin Oncol,2000

5. Epidermal growth factor receptor inhibitors in the treatment of non-small-cell lung cancer;Giaccone;J Clin Oncol,2005

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Angiogenesis in Non-small Cell Lung Cancer Tumor Behavior;Biochemical Basis and Therapeutic Implications of Angiogenesis;2017

2. Polimorfismos genéticos e carcinoma de pulmão de células não pequenas: os paradigmas do futuro;Einstein (São Paulo);2014-11-18

3. EGFR and KRAS mutations, and ALK fusions: current developments and personalized therapies for patients with advanced non-small-cell lung cancer;Pharmacogenomics;2013-11

4. The Impact of Polymorphic Variations in the 5p15, 6p12, 6p21 and 15q25 Loci on the Risk and Prognosis of Portuguese Patients with Non-Small Cell Lung Cancer;PLoS ONE;2013-09-06

5. Anaplastic lymphoma kinase gene rearrangement and non-small cell lung cancer management: a step forward in personalized therapy;Clinics;2013-05-17